This topic contains a solution. Click here to go to the answer

Author Question: A specialized high-speed conduction system begins at which of the following points? a. A c. D b. ... (Read 27 times)

JGIBBSON

  • Hero Member
  • *****
  • Posts: 538
A specialized high-speed conduction system begins at which of the following points?
 
  a. A c. D
  b. C d. H

Question 2

The fifth intercostal space on the anterior axillary line is the site for which of the following elec-trocardiogram leads?
 
  a. V3 c. V5
  b. V4 d. V6



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

BUTTHOL369

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

ANS: D
Electrical impulses move through a series of high-speed internodal conduction pathways between the sinoatrial and atrioventricular nodes.

Answer to Question 2

ANS: C
V5 is located at the same level as V4 (fifth intercostal space) on the anterior axillary line.




JGIBBSON

  • Member
  • Posts: 538
Reply 2 on: Jul 16, 2018
Thanks for the timely response, appreciate it


ashely1112

  • Member
  • Posts: 347
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library